Why is Gland Pharma falling/rising?

As of 29-Aug, Gland Pharma Ltd's stock price is currently at 1,885.00, reflecting an increase of 5.4 (0.29%). The stock has shown a trend reversal, gaining after three consecutive days of decline. It has outperformed its sector by 0.26% today, with a notable rise in delivery volume, which increased by 15.31% against the 5-day average. Despite a negative return of -9.97% over the past month, the stock has a year-to-date return of +5.39%, indicating some resilience. The company benefits from a low debt-to-equity ratio and strong institutional holdings at 40.24%, which may provide stability and confidence among investors.
In the broader market context, Gland Pharma's recent performance contrasts with the Sensex, which has declined by -1.84% over the past week and -1.88% over the past month. This suggests that while Gland Pharma has faced challenges, it is managing to maintain a relatively better position compared to the overall market. The stock's performance over the last three years has been significantly weaker than the benchmark, with a decline of -19.47% compared to a +37.67% increase in the Sensex. However, the positive quarterly results reported in June, including record net sales and growth in profit before tax, may be contributing to the current upward movement in the stock price.